Special Issue "Intracerebral Hemorrhage: Treatment in 2023 and Beyond"

A special issue of Journal of Clinical Medicine (ISSN 2077-0383). This special issue belongs to the section "Clinical Neurology".

Deadline for manuscript submissions: 31 December 2023 | Viewed by 85

Special Issue Editors

Department of Neurology Disease, Chongqing Medical University, Chengdu, China
Interests: intracerebral hemorrhage; risk factors; imaging; treatment; management; prognosis.
Emergency Department, The Affiliated Hospital of Guizhou Medical University, Guiyang 550004, China
Interests: intracerebral hemorrhage; risk factors; imaging; treatment; management; prognosis.
Prof. Dr. Zhe Kang Law
E-Mail Website
Guest Editor
Neurology Unit, Department of Medicine, UKM Medical Centre, National University of Malaysia, Kuala Lumpur, Malaysia
Interests: intracerebral hemorrhage

Special Issue Information

Dear Colleagues,

Intracerebral hemorrhage (ICH) is a devastating subtype of stroke characterized by bleeding occurring in the brain parenchyma and remains a considerable source of morbidity and mortality globally. Hematoma expansion, intraventricular hemorrhage, and perihematomal edema have been well established as modifiable predictors of functional outcome after ICH. Therefore, targeting the important modifiable determinants of prognosis are critical for improving functional outcome. Modulation of blood pressure, anti-coagulant reversal hemostatic therapies, and surgical evacuation of the hematoma are promising treatment options for ICH. Although tremendous strides in effective acute therapy of ischemic stroke have occurred in the past years, ICH remains a devastating condition with few evidence-based treatment options. Furthermore, understanding of risk factors and complications of ICH are also important for individualized management. Therefore, developing novel therapies and streamlined management protocols for ICH are crucial for improving functional outcome and alleviate associated stroke burden. In this Special Issue entitled “Intracerebral Hemorrhage: Treatment in 2023 and Beyond”, we call for research and review articles focusing on evaluation, treatment techniques, and therapeutic strategies for patients with ICH.

We are looking forward to your contributions! 

Prof. Dr. Qi Li
Prof. Dr. Guofeng Wu
Prof. Dr. Zhe Kang Law
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Clinical Medicine is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.


  • intracerebral hemorrhage
  • risk factors
  • imaging
  • treatment
  • management
  • prognosis

Published Papers

This special issue is now open for submission.
Back to TopTop